col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Frontiers Media SA: Frontiers in Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―25 Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus Alexander Suvorov, Tatiana Gupalova, Yulia Desheva, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, et al. (+2)
2 [GO] 2022―Jan―21 Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review Ying Wang, Kun Zhu, Rulin Dai, Rui Li, Miao Li, Xin Lv, Qian Yu
3 [GO] 2022―Jan―20 Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Yunyun Quan, Li Li, Zhujun Yin, Shilong Chen, Jing Yi, Jirui Lang, et al. (+3)
4 [GO] 2022―Jan―19 Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro Senem Merve Fred, Suvi Kuivanen, Hasan Ugurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, et al. (+2)
5 [GO] 2022―Jan―13 COVID-19 and Periodontitis: A Dangerous Association? Francisco Javier Silvestre, Cecilia Fabiana Márquez-Arrico
6 [GO] 2022―Jan―12 Editorial: Biomolecules Against Coronaviruses: Molecular Aspects, Multi-Omics and Systems Pharmacology Christophe Hano, Ilaria Peluso, Jen-Tsung Chen
7 [GO] 2022―Jan―12 The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, Elizabeth Marie Gavioli, Flavio Mantelli, Marcello Allegretti, Robert A. Balk
8 [GO] 2022―Jan―12 Angiotensin-Converting Enzyme Genotype-Specific Immune Response Contributes to the Susceptibility of COVID-19: A Nested Case-Control Study Pengyun Gong, Fanghua Mei, Ruili Li, Yuchen Wang, Weizheng Li, Kai Pan, et al. (+5)
9 [GO] 2022―Jan―06 Opioids in COVID-19: Two Sides of a Coin Camila Vantini Capasso Palamim, Matheus Negri Boschiero, Aléthea Guimarães Faria, Felipe Eduardo Valencise, Fernando Augusto Lima Marson
10 [GO] 2022―Jan―05 The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, et al. (+3)
11 [GO] 2022―Jan―05 Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus Alexander Suvorov, Tatiana Gupalova, Yulia Desheva, Tatiana Kramskaya, Elena Bormotova, Irina Koroleva, et al. (+2)
12 [GO] 2022―Jan―04 Perception, Attitude, and Confidence of Physicians About Antimicrobial Resistance and Antimicrobial Prescribing Among COVID-19 Patients: A Cross-Sectional Study From Punjab, Pakistan Khezar Hayat, Zia Ul Mustafa, Muhammad Nabeel Ikram, Muhammad Ijaz-Ul-Haq, Irum Noor, Muhammad Fawad Rasool, et al. (+4)
13 [GO] 2021―Dec―24 Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering Fan Yang, Qi Zhang, Zhongshang Yuan, Saisai Teng, Lizhen Cui, Fuzhong Xue, Leyi Wei
14 [GO] 2021―Dec―23 Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19 Wenjiang Zheng, Ting Wang, Peng Wu, Qian Yan, Chengxin Liu, Hui Wu, et al. (+4)
15 [GO] 2021―Dec―23 Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern Khursheed Ul Islam, Thoraya Mohamed Elhassan A-Elgadir, Sarah Afaq, Tanveer Ahmad, Jawed Iqbal
16 [GO] 2021―Dec―22 Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19 Pandemic: A Study From Jordan Sura Al Zoubi, Lobna Gharaibeh, Hatim M. Jaber, Zaha Al-Zoubi
17 [GO] 2021―Dec―17 Corrigendum: Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, et al. (+3)
18 [GO] 2021―Dec―16 Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants Oleg O. Glebov
19 [GO] 2021―Dec―10 Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital Alice Ramos Oliveira Silva, Diamantino Ribeiro Salgado, Luis Phillipe Nagem Lopes, Débora Castanheira, Isabel Cristina Martins Emmerick, Elisangela Costa Lima
20 [GO] 2021―Dec―08 Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System Michele Fusaroli, Emanuel Raschi, Milo Gatti, Fabrizio De Ponti, Elisabetta Poluzzi
21 [GO] 2021―Dec―06 Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery Maria Yu. Zakharova, Alexandra A. Kuznetsova, Victoria I. Uvarova, Anastasiia D. Fomina, Liubov I. Kozlovskaya, Elena N. Kaliberda, et al. (+11)
22 [GO] 2021―Dec―03 Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic Jia-bo Wang, Adolfo Andrade-Cetto, Javier Echeverria, Jon Wardle, Hung-Rong Yen, Michael Heinrich
23 [GO] 2021―Dec―01 Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources Rajeev K. Singla, Xuefei He, Hitesh Chopra, Christos Tsagkaris, Li Shen, Mohammad Amjad Kamal, Bairong Shen
24 [GO] 2021―Dec―01 Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19 Qian-hui Zhang, Hao-zhou Huang, Min Qiu, Zhen-feng Wu, Zhan-chang Xin, Xin-fu Cai, et al. (+4)
25 [GO] 2021―Nov―22 Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment Houwen Zou, Yuqi Yang, Huiqiang Dai, Yunchuang Xiong, Jing-Quan Wang, Lusheng Lin, Zhe-Sheng Chen
26 [GO] 2021―Nov―19 Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells Oghenemega Okoloko, Elizabeth R. Vanderwall, Lucille M. Rich, Maria P. White, Stephen R. Reeves, Whitney E. Harrington, et al. (+2)
27 [GO] 2021―Nov―18 The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy, Sang-Soo Lee
28 [GO] 2021―Nov―18 Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study Keiko Ogawa-Ochiai, Hideki Ishikawa, Hongyang Li, Lam Vu Quang, Izumi Kimoto, Mitsuyuki Takamura, et al. (+7)
29 [GO] 2021―Nov―11 Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy Linhu Ye, Lei Cheng, Yan Deng, Hong Liu, Xinyu Wu, Tingting Wang, et al. (+5)
30 [GO] 2021―Nov―11 Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2 Shufen Li, Meidi Ye, Yuanqiao Chen, Yulan Zhang, Jiachen Li, Wei Liu, et al. (+2)
31 [GO] 2021―Nov―08 A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV Sitesh C. Bachar, Kishor Mazumder, Ritesh Bachar, Asma Aktar, Mamun Al Mahtab
32 [GO] 2021―Nov―08 Breaking Barriers Amid the Pandemic: The Status of Telehealth in Southeast Asia and its Potential as a Mode of Healthcare Delivery in the Philippines Aitana Dy Macariola, Theara Mae Capacion Santarin, Ferianne Joy Manday Villaflor, Leofe Marie Guintos Villaluna, Rea Shane Leonora Yonzon, Jamie Ledesma Fermin, et al. (+4)
33 [GO] 2021―Nov―04 Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis Yanni Lai, Tiantian Han, Zizhao Lao, Geng Li, Jianyong Xiao, Xiaohong Liu
34 [GO] 2021―Nov―02 Commentary: Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated With SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking Congchao Jia, Xinya Peng, Hao Chi, Gang Tian
35 [GO] 2021―Oct―26 Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy Yujia Li, Bin Li, Pan Wang, Qinghua Wang
36 [GO] 2021―Oct―25 Clinical Characteristics and Inflammatory Immune Responses in COVID-19 Patients With Hypertension: A Retrospective Study Chaoran Wu, Guangbo Qu, Lei Wang, Shiyu Cao, Dandan Xia, Baolong Wang, et al. (+2)
37 [GO] 2021―Oct―25 Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip Amir Bein, Seongmin Kim, Girija Goyal, Wuji Cao, Cicely Fadel, Arash Naziripour, et al. (+17)
38 [GO] 2021―Oct―25 Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, et al. (+8)
39 [GO] 2021―Oct―25 Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells Jan Papies, Jackson Emanuel, Nicolas Heinemann, Žarko Kulić, Simon Schroeder, Beate Tenner, et al. (+3)
40 [GO] 2021―Oct―18 The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review Antonio Addis, Laura Amato, Fabio Cruciani, Rosella Saulle, Franco De Crescenzo, Zuzana Mitrova, et al. (+3)
41 [GO] 2021―Oct―14 Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19 Zaigham Abbas Rizvi, Manas Ranjan Tripathy, Nishant Sharma, Sandeep Goswami, N Srikanth, J. L. N. Sastry, et al. (+4)
42 [GO] 2021―Oct―01 The Establishment and Practice of Pharmacy Care Service Based on Internet Social Media: Telemedicine in Response to the COVID-19 Pandemic Huibo Li, Siqian Zheng, Da Li, Dechun Jiang, Fang Liu, Wei Guo, et al. (+4)
43 [GO] 2021―Sep―17 Immunotherapy Summary for Cytokine Storm in COVID-19 Yaqun Li, Wenjie Zhao, Jinhua Liu, Zichao Chen, Qingtao Lv, Zhen Zhang
44 [GO] 2021―Sep―15 Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Xu-Qin Du, Li-Peng Shi, Wen-Fu Cao, Zhi-Wei Chen, Biao Zuo, Jin-Yuan Hu
45 [GO] 2021―Sep―09 Therapeutic Potential of Annexins in Sepsis and COVID-19 Louise Mui, Claudio M. Martin, Brent J. Tschirhart, Qingping Feng
46 [GO] 2021―Sep―09 Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes Maha Al Ammari, Khalefa AlThiab, Manal AlJohani, Khizra Sultana, Nada Maklhafi, Hayel AlOnazi, Aswaq Maringa
47 [GO] 2021―Sep―06 Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation Hongjuan Lu, Yuanqiong Wang, Xiuwen Wang, Xin Wu, Ling Zhou, Li Lin, et al. (+4)
48 [GO] 2021―Sep―06 Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics Abdul Basit, Asad Mustafa Karim, Muhammad Asif, Tanveer Ali, Jung Hun Lee, Jeong Ho Jeon, et al. (+2)
49 [GO] 2021―Sep―04 A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients Riccardo Giossi, Danilo Menichelli, Arianna Pani, Elena Tratta, Alessandra Romandini, Rossana Roncato, et al. (+7)
50 [GO] 2021―Sep―04 Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial Chang Chen, Yi Zhang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, et al. (+8)
51 [GO] 2021―Sep―04 Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines Ying Wu, Ping Zhong
52 [GO] 2021―Sep―04 Targeting of Protein’s Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L Ochuko L. Erukainure, Motlalepula G. Matsabisa, Aliyu Muhammad, Musa M. Abarshi, James F. Amaku, Sanusi B. Katsayal, Adeline Lum Nde
53 [GO] 2021―Sep―03 Identification of Novel Gene Signatures using Next-Generation Sequencing Data from COVID-19 Infection Models: Focus on Neuro-COVID and Potential Therapeutics Peter Natesan Pushparaj, Angham Abdulrahman Abdulkareem, Muhammad Imran Naseer
54 [GO] 2021―Aug―31 Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, Matthew Moon, Laura E. Phelps, Oliver Grundmann
55 [GO] 2021―Aug―27 Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties Wei-Chung Chiou, Hsu-Feng Lu, Nung-Yu Hsu, Tein-Yao Chang, Yuan-Fan Chin, Ping-Cheng Liu, et al. (+4)
56 [GO] 2021―Aug―24 Editorial: Drug Repurposing for COVID-19 Therapy Rafael Maldonado, Filippo Drago
57 [GO] 2021―Aug―23 mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis Simona Granata, Pierluigi Carraté, Giovanni Stallone, Gianluigi Zaza
58 [GO] 2021―Aug―18 Drug-Induced Liver Disturbance During the Treatment of COVID-19 Guanghua Zhai, Meifen Li, Ying Wang, Jian Wu
59 [GO] 2021―Aug―17 Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 Wei Chen, Zhihao Wang, Yawen Wang, Yiping Li
60 [GO] 2021―Aug―13 Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2 Hsing-Yu Hsu, Cheng-Wei Yang, Yue-Zhi Lee, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, et al. (+9)
61 [GO] 2021―Aug―12 Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen-Case Series Report Damir Vukoja, Andrea Jurić, Zdravka Erkapić, Tomislav Pejić, Željko Zovko, Josipa Juričić, et al. (+2)
62 [GO] 2021―Aug―12 Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis Qi Wang, Hongfei Zhu, Mengting Li, Yafei Liu, Honghao Lai, Qiuyu Yang, et al. (+2)
63 [GO] 2021―Aug―11 A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature Cameron Mura, Saskia Preissner, Robert Preissner, Philip E. Bourne
64 [GO] 2021―Aug―09 Case Report: Can Inhaled Adenosine Attenuate COVID-19? Bruce D. Spiess, Michael Sitkovsky, Pierpaolo Correale, Nikolaus Gravenstein, Cynthia Garvan, Timothy E. Morey, et al. (+7)
65 [GO] 2021―Aug―06 Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis Heping Wang, Bowen Xu, Ying Zhang, Yuanyuan Duan, Ruike Gao, Haoqiang He, et al. (+2)
66 [GO] 2021―Aug―06 Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics Bérénice Charrez, Verena Charwat, Brian A. Siemons, Ishan Goswami, Courtney Sakolish, Yu-Syuan Luo, et al. (+5)
67 [GO] 2021―Aug―06 The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models Scott P. Davies, Courtney J. Mycroft-West, Isabel Pagani, Harriet J. Hill, Yen-Hsi Chen, Richard Karlsson, et al. (+10)
68 [GO] 2021―Aug―05 NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments Constant Gillot, Julien Favresse, François Mullier, Thomas Lecompte, Jean-Michel Dogné, Jonathan Douxfils
69 [GO] 2021―Jul―28 Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19 Daniel P. Smith, Olly Oechsle, Michael J. Rawling, Ed Savory, Alix M.B. Lacoste, Peter John Richardson
70 [GO] 2021―Jul―28 Ten Rules for Conducting Retrospective Pharmacoepidemiological Analyses: Example COVID-19 Study Michael Powell, Allison Koenecke, James Brian Byrd, Akihiko Nishimura, Maximilian F. Konig, Ruoxuan Xiong, et al. (+10)
71 [GO] 2021―Jul―20 Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola
72 [GO] 2021―Jul―20 Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong Methee Phumthum, Varangrat Nguanchoo, Henrik Balslev
73 [GO] 2021―Jul―16 The Role of High-Density Lipoprotein in COVID-19 Guyi Wang, Jiayi Deng, Jinxiu Li, Chenfang Wu, Haiyun Dong, Shangjie Wu, Yanjun Zhong
74 [GO] 2021―Jul―16 Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy† Ghazaleh Mosleh, Parmis Badr, Meysam Zaeri, Abdolali Mohagheghzadeh
75 [GO] 2021―Jul―15 Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, et al. (+8)
76 [GO] 2021―Jul―09 Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19 Zhong Sun, Guozhong He, Ninghao Huang, Karuppiah Thilakavathy, Jonathan Chee Woei Lim, S. Suresh Kumar, Chenglong Xiong
77 [GO] 2021―Jul―08 Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening Saranya Nallusamy, Jayakanthan Mannu, Caroline Ravikumar, Kandavelmani Angamuthu, Bharathi Nathan, Kumaravadivel Nachimuthu, et al. (+4)
78 [GO] 2021―Jul―07 Herbal Medicine, Gut Microbiota, and COVID-19 Ziqi Chen, Yiwen Lv, Huachong Xu, Li Deng
79 [GO] 2021―Jul―07 Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations Faez Iqbal Khan, Tongzhou Kang, Haider Ali, Dakun Lai
80 [GO] 2021―Jul―05 Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis Dermot Cox
81 [GO] 2021―Jul―02 Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study Qiang Wang, Haipeng Guo, Yu Li, Xiangdong Jian, Xinguo Hou, Ning Zhong, et al. (+14)
82 [GO] 2021―Jul―01 High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 Mario Karolyi, Sara Omid, Erich Pawelka, Bernd Jilma, Thomas Stimpfl, Christian Schoergenhofer, et al. (+5)
83 [GO] 2021―Jul―01 Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment Luis Sarabia De Ardanaz, Jose M. Andreu-Ubero, Miriam Navidad-Fuentes, Miguel Ángel Ferrer-González, Victor Ruíz del Valle, Inmaculada Salcedo-Bellido, et al. (+3)
84 [GO] 2021―Jun―29 The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Shengguang Wang, Zhen Li, Xinyu Wang, Shiming Zhang, Peng Gao, Zuorong Shi
85 [GO] 2021―Jun―29 Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection Seyed Abdulmajid Ayatollahi, Javad Sharifi-Rad, Patrick Valere Tsouh Fokou, Gail B. Mahady, Hafiz Ansar Rasul Suleria, Shivani Krishna Kapuganti, et al. (+9)
86 [GO] 2021―Jun―24 Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19 Charu Sharma, Niraj Kumar Jha, M. F. Nagoor Meeran, Chandragouda R. Patil, Sameer N. Goyal, Shreesh Ojha
87 [GO] 2021―Jun―23 Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials Shin Takayama, Takao Namiki, Hiroshi Odaguchi, Ryutaro Arita, Akito Hisanaga, Kazuo Mitani, Takashi Ito
88 [GO] 2021―Jun―21 Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants Ziwei Hu, Jinhong Lin, Jintao Chen, Tengxi Cai, Lixin Xia, Ying Liu, et al. (+2)
89 [GO] 2021―Jun―18 He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study Haibo Hu, Kun Wang, Li Wang, Yanjun Du, Juan Chen, Yongchun Li, et al. (+7)
90 [GO] 2021―Jun―17 The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19 M. Ekholm, T. Kahan
91 [GO] 2021―Jun―17 Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation Ting Xiao, Mengqi Cui, Caijuan Zheng, Ming Wang, Ronghao Sun, Dandi Gao, et al. (+8)
92 [GO] 2021―Jun―16 Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences Elena Campione, Caterina Lanna, Terenzio Cosio, Luigi Rosa, Maria Pia Conte, Federico Iacovelli, et al. (+25)
93 [GO] 2021―Jun―14 A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2 Kaleb B. Tsegay, Christiana M. Adeyemi, Edward P. Gniffke, D. Noah Sather, John K. Walker, Stephen E. P. Smith
94 [GO] 2021―Jun―14 Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021 Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, S. M. Abdur Rahman, Isa Naina Mohamed
95 [GO] 2021―Jun―11 A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency Elizabeth M. Sajdel-Sulkowska
96 [GO] 2021―Jun―10 Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2 Wenjiang Zheng, Xiufang Huang, Yanni Lai, Xiaohong Liu, Yong Jiang, Shaofeng Zhan
97 [GO] 2021―Jun―07 Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19 Clarissa S. Santoso, Zhaorong Li, Jaice T. Rottenberg, Xing Liu, Vivian X. Shen, Juan I. Fuxman Bass
98 [GO] 2021―Jun―07 A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic Tamás Ágh, Job FM van Boven, Björn Wettermark, Enrica Menditto, Hilary Pinnock, Ioanna Tsiligianni, et al. (+4)
99 [GO] 2021―Jun―07 Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential Xinyu Cui, Wuyue Chen, Haoyan Zhou, Yuan Gong, Bowen Zhu, Xiang Lv, et al. (+5)
100 [GO] 2021―Jun―04 The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects Gianluca Cappelleri, Andrea Fanelli, Daniela Ghisi, Gianluca Russo, Antonio Giorgi, Vito Torrano, et al. (+3)
101 [GO] 2021―Jun―03 Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City Oscar Arturo Lozano-Cruz, José Víctor Jiménez, Antonio Olivas-Martinez, Edgar Ortiz-Brizuela, José Luis Cárdenas-Fragoso, Daniel Azamar-Llamas, et al. (+13)
102 [GO] 2021―May―28 Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial Kirti S Pawar, Rahul N Mastud, Satheesh K Pawar, Samragni S Pawar, Rahul R Bhoite, Ramesh R Bhoite, et al. (+2)
103 [GO] 2021―May―28 Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, Fahmida Tasnim Richi, Chao Zhao, Jin-Rong Zhou, Isa Naina Mohamed
104 [GO] 2021―May―26 The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19 Peng Li, Shuang Hu, Cheng Qian, Yan Yao, Liang-yun Li, Jun-fa Yang, et al. (+10)
105 [GO] 2021―May―26 Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease Bin Cheng, Jinxiu Ma, Yani Yang, Tingting Shao, Binghao Zhao, Linxiang Zeng
106 [GO] 2021―May―25 COVID-19-Associated Pneumonia: Radiobiological Insights Sabine François, Carole Helissey, Sophie Cavallero, Michel Drouet, Nicolas Libert, Jean-Marc Cosset, et al. (+3)
107 [GO] 2021―May―20 A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients Alain Bousquet-Mélou, Anne Lespine, Jean-François Sutra, Isabelle Bargues, Pierre-Louis Toutain
108 [GO] 2021―May―14 β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19 Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, et al. (+3)
109 [GO] 2021―May―14 Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining Mingfei Shi, Bo Peng, An Li, Ziyun Li, Ping Song, Jing Li, et al. (+2)
110 [GO] 2021―May―13 Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19 Daniela Peruzzu, Maria Teresa Pagano, Marina Pierdominici, Anna Ruggieri, Andrea Antinori, Gianpiero D’Offizi, et al. (+11)
111 [GO] 2021―May―12 Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19 Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, et al. (+5)
112 [GO] 2021―May―07 Curcumin as a Potential Treatment for COVID-19 Bruna A. C. Rattis, Simone G. Ramos, Mara R. N. Celes
113 [GO] 2021―May―07 The Anti-Viral and Anti-Inflammatory Properties of Edible Bird’s Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application Kien Hui Chua, Isa Naina Mohamed, Mohd Heikal Mohd Yunus, Norefrina Shafinaz Md Nor, Khidhir Kamil, Azizah Ugusman, Jaya Kumar
114 [GO] 2021―May―06 The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19 Elangovan Manivannan, Chandrabose Karthikeyan, N. S. Hari Narayana Moorthy, Subash Chandra Chaturvedi
115 [GO] 2021―May―03 Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management Akash Saggam, Kirti Limgaokar, Swapnil Borse, Preeti Chavan-Gautam, Santosh Dixit, Girish Tillu, Bhushan Patwardhan
116 [GO] 2021―May―03 A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2? Vincenzo Patella, Alessandro Sanduzzi, Dario Bruzzese, Giovanni Florio, Raffaele Brancaccio, Gabriella Fabbrocini, Gabriele Delfino
117 [GO] 2021―May―03 Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natália Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, et al. (+10)
118 [GO] 2021―May―03 Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis Franco De Crescenzo, Laura Amato, Fabio Cruciani, Luke P Moynihan, Gian Loreto D’Alò, Simona Vecchi, et al. (+5)
119 [GO] 2021―Apr―30 Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation Ming Cai, Xuan Chen, Jieling Shan, Ruoyu Yang, Qi Guo, Xia Bi, et al. (+4)
120 [GO] 2021―Apr―28 Edible and Herbal Plants for the Prevention and Management of COVID-19 Sha Li, Chien-Shan Cheng, Cheng Zhang, Guo-Yi Tang, Hor-Yue Tan, Hai-Yong Chen, et al. (+3)
121 [GO] 2021―Apr―26 Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola
122 [GO] 2021―Apr―26 Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective Samir K. Beura, Abhishek R. Panigrahi, Pooja Yadav, Sunil K. Singh
123 [GO] 2021―Apr―23 Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mohammed Alqarni, Natália Cruz-Martins, Gaber El-Saber Batiha
124 [GO] 2021―Apr―22 SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, Haseeb A. Khan, Salman H. Alrokayan, N. Rajendra Prasad
125 [GO] 2021―Apr―22 High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study Bing Zhao, Min Liu, Ping Liu, Yibing Peng, Jun Huang, Mengjiao Li, et al. (+9)
126 [GO] 2021―Apr―22 No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, Fabrizio Taglietti, Alessandra Vergori, Amina Abdeddaim, et al. (+15)
127 [GO] 2021―Apr―20 The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, Antonella De Angelis, Konrad Urbanek, Gabriella di Mauro, et al. (+4)
128 [GO] 2021―Apr―20 Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, Vidula V. Sukhatme
129 [GO] 2021―Apr―20 SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression Swati Goel, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif Askari, Bushra Madkhana, Ahmad Munzer Alwaa, Bassam Mahboub, et al. (+5)
130 [GO] 2021―Apr―19 Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish Acharya Balkrishna, Lakshmipathi Khandrika, Anurag Varshney
131 [GO] 2021―Apr―16 Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection Kauê Francisco Corrêa Souza e Souza, Bianca Portugal Tavares Moraes, Izabel Christina Nunes de Palmer Paixão, Patrícia Burth, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque
132 [GO] 2021―Apr―12 Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 Claudio Iovino, Enrico Peiretti, Giuseppe Giannaccare, Vincenzo Scorcia, Adriano Carnevali
133 [GO] 2021―Apr―12 Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019 Maurizio Bifulco, Donatella Fiore, Chiara Piscopo, Patrizia Gazzerro, Maria Chiara Proto
134 [GO] 2021―Apr―12 Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity Siya Kamat, Madhuree Kumari
135 [GO] 2021―Apr―12 Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking De Jin, Xuedong An, Yuqing Zhang, Shenghui Zhao, Liyun Duan, Yingying Duan, et al. (+2)
136 [GO] 2021―Apr―12 Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential Fadia S. Youssef, Ahmed E. Altyar, Abdelsattar M. Omar, Mohamed L. Ashour
137 [GO] 2021―Apr―01 Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review Cristina Mondello, Salvatore Roccuzzo, Orazio Malfa, Daniela Sapienza, Patrizia Gualniera, Elvira Ventura Spagnolo, et al. (+4)
138 [GO] 2021―Mar―29 Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials Rodolfo Pedro Rothlin, Mariano Duarte, Facundo Germán Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Miguel Vetulli, Eduardo Spitzer
139 [GO] 2021―Mar―26 Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen Jordi Rodon, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Roger Paredes, Lourdes Mateu, et al. (+12)
140 [GO] 2021―Mar―25 Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020 Andy R. Eugene, Beata Eugene, Marek Masiak, Jolanta Sylwia Masiak
141 [GO] 2021―Mar―24 Medicinal Plants in COVID-19: Potential and Limitations Xin Yi Lim, Bee Ping Teh, Terence Yew Chin Tan
142 [GO] 2021―Mar―23 COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, et al. (+19)
143 [GO] 2021―Mar―23 Proactive Measures to Combat a SARS-CoV-2 Transmission Among High Risk Patients and Health Care Workers in an Outpatient Dialysis Facility Jayandiran Pillai, Pagollang Motloba, Keolebogile Shirley Caroline Motaung, Carole Wallis, Lovelyn Uzoma Ozougwu, Debashis Basu
144 [GO] 2021―Mar―22 Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients Sichao Chen, Jinpeng Li, Zeming Liu, Danyang Chen, Ling Zhou, Di Hu, et al. (+9)
145 [GO] 2021―Mar―19 Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug Fatih M. Uckun, Saran Saund, Hitesh Windlass, Vuong Trieu
146 [GO] 2021―Mar―15 Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis Zeinab Abdelrahman, Qian Liu, Shanmei Jiang, Mengyuan Li, Qingrong Sun, Yue Zhang, Xiaosheng Wang
147 [GO] 2021―Mar―10 Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing Charlotte Kern, Verena Schöning, Carlos Chaccour, Felix Hammann
148 [GO] 2021―Mar―09 Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology Daniele Pala, Marco Pistis
149 [GO] 2021―Mar―09 Plant Products as Inhibitors of Coronavirus 3CL Protease Anirban Mandal, Ajeet Kumar Jha, Banasri Hazra
150 [GO] 2021―Mar―09 The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet
151 [GO] 2021―Mar―08 An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha
152 [GO] 2021―Mar―04 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection Rui Hong Chen, Li Jun Yang, Sami Hamdoun, Sookja Kim Chung, Christopher Wai-kei Lam, Kai Xi Zhang, et al. (+4)
153 [GO] 2021―Mar―02 Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, et al. (+4)
154 [GO] 2021―Mar―02 Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, et al. (+2)
155 [GO] 2021―Mar―02 Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research Sayeed Ahmad, Sultan Zahiruddin, Bushra Parveen, Parakh Basist, Abida Parveen, Rabea Parveen, Minhaj Ahmad
156 [GO] 2021―Mar―01 A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management Muhammad Harris Shoaib, Farrukh Rafiq Ahmed, Muhammad Sikandar, Rabia Ismail Yousuf, Muhammad Talha Saleem
157 [GO] 2021―Feb―26 In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19 Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, et al. (+20)
158 [GO] 2021―Feb―26 A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review Priyanka Dash, Subhashree Mohapatra, Sayantan Ghosh, Bismita Nayak
159 [GO] 2021―Feb―26 Chinese Herbal Medicine Used With or Without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies Shi-Bing Liang, Ying-Ying Zhang, Chen Shen, Chang-Hao Liang, Bao-Yong Lai, Ning Dai, et al. (+9)
160 [GO] 2021―Feb―26 Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach Satabdi Saha, Rajat Nandi, Poonam Vishwakarma, Amresh Prakash, Diwakar Kumar
161 [GO] 2021―Feb―25 Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China Jieya Wu, Baoguo Sun, Li Hou, Fulan Guan, Liyuan Wang, Peikwen Cheng, et al. (+3)
162 [GO] 2021―Feb―23 The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection Mohammad Reza Kalhori, Fatemeh Saadatpour, Ehsan Arefian, Masoud Soleimani, Mohammad Hosien Farzaei, Ina Yosifova Aneva, Javier Echeverría
163 [GO] 2021―Feb―22 Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease Luca Pinzi, Annachiara Tinivella, Fabiana Caporuscio, Giulio Rastelli
164 [GO] 2021―Feb―13 Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients Miao Zhang, Xueting Yao, Zhe Hou, Xuan Guo, Siqi Tu, Zihan Lei, et al. (+10)
165 [GO] 2021―Feb―13 Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review Fui Fui Lem, Fernandes Opook, Dexter Jiunn Herng Lee, Fong Tyng Chee, Fahcina P. Lawson, Su Na Chin
166 [GO] 2021―Feb―09 COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses Jingcheng Wu, Wenfan Chen, Jingjing Zhou, Wenyi Zhao, Yisheng Sun, Hanping Zhu, et al. (+4)
167 [GO] 2021―Feb―08 Modalities and Mechanisms of Treatment for Coronavirus Disease 2019 Zhihong Zuo, Ting Wu, Liangyu Pan, Chenzhe Zuo, Yingchuo Hu, Xuan Luo, et al. (+6)
168 [GO] 2021―Feb―05 Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019 Jingyuan Liu, Yuyong Jiang, Yao Liu, Lin Pu, Chunjing Du, Yuxin Li, et al. (+8)
169 [GO] 2021―Feb―05 Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, et al. (+6)
170 [GO] 2021―Feb―04 Chemokine Regulation During Epidemic Coronavirus Infection Shamik Majumdar, Philip M. Murphy
171 [GO] 2021―Feb―01 Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease Hylemariam Mihiretie Mengist, Daniel Mekonnen, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin
172 [GO] 2021―Jan―29 Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 Nina V. Vorobjeva, Galina F. Sud'ina, Boris V. Chernyak
173 [GO] 2021―Jan―29 What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19 Vicki Osborne, Saad A. W. Shakir
174 [GO] 2021―Jan―29 HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons Andrey A. Poloznikov, Stepan A. Nersisyan, Dmitry M. Hushpulian, Eliot H. Kazakov, Alexander G. Tonevitsky, Sergey V. Kazakov, et al. (+4)
175 [GO] 2021―Jan―29 Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections Bao Sun, Shiqiong Huang, Jiecan Zhou
176 [GO] 2021―Jan―27 Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19 Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana
177 [GO] 2021―Jan―26 Potential of Immune-Related Therapy in COVID-19 Chunjue Yuan, Ruoyun Li, Guohong Liu, Yunbao Pan
178 [GO] 2021―Jan―26 Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Sergio Verd, Mateo Verd
179 [GO] 2021―Jan―25 Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 Catherine Z. Chen, Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen, et al. (+13)
180 [GO] 2021―Jan―20 Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei, Javier Echeverría
181 [GO] 2021―Jan―19 Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond Alpo Vuorio, Petri T. Kovanen
182 [GO] 2021―Jan―15 Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications Israel Abebrese Sefah, Olayinka O. Ogunleye, Darius Obeng Essah, Sylvia A. Opanga, Nadia Butt, Annie Wamaitha, et al. (+20)
183 [GO] 2021―Jan―15 Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications Mainul Haque, Santosh Kumar, Jaykaran Charan, Rohan Bhatt, Salequl Islam, Siddhartha Dutta, et al. (+6)
184 [GO] 2021―Jan―15 TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target Gillina F. G. Bezemer, Johan Garssen
185 [GO] 2021―Jan―14 Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19 Damir Bojadzic, Oscar Alcazar, Peter Buchwald
186 [GO] 2021―Jan―14 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor Taizhen Liang, Jiayin Qiu, Xiaoge Niu, Qinhai Ma, Chenliang Zhou, Pei Chen, et al. (+5)
187 [GO] 2021―Jan―14 Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies Voddu Suresh, Deepti Parida, Aliva P. Minz, Manisha Sethi, Bhabani S. Sahoo, Shantibhusan Senapati
188 [GO] 2021―Jan―11 A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection Juwairiah Remali, Wan Mohd Aizat
189 [GO] 2021―Jan―10 The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19 Emmanuel Stip, Tahir A. Rizvi, Farah Mustafa, Syed Javaid, Salahdein Aburuz, Nahida Nayaz Ahmed, et al. (+5)
190 [GO] 2021―Jan―10 Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos, Andria dos Santos Freitas, Wagner Rodrigues de Assis Soares, Sérgio Siqueira, et al. (+4)
191 [GO] 2021―Jan―10 Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis Qi Han, Mingyue Guo, Yue Zheng, Ying Zhang, Yanshan De, Changchang Xu, et al. (+7)
192 [GO] 2021―Jan―10 Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report Christopher E. Rudd
193 [GO] 2021―Jan―07 Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review Mudit Agarwal, Piyush Ranjan, Upendra Baitha, Ankit Mittal
194 [GO] 2020―Dec―28 Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri, Lorenzo Dagna
195 [GO] 2020―Dec―23 Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient Andrea Montesel, Claudio Bucolo, Victoria Mouvet, Emmanuelle Moret, Chiara M. Eandi
196 [GO] 2020―Dec―21 D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China Jinpeng Li, Zeming Liu, Gaosong Wu, Meilin Yi, Yongfeng Chen, Kun Li, et al. (+5)
197 [GO] 2020―Dec―21 COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments Natalia Soldevila-Domenech, Laura Tío, Jone Llorente-Onaindia, Elena Martín-García, Pau Nebot, Rafael de la Torre, et al. (+3)
198 [GO] 2020―Dec―18 COVID-19 Disease and Vitamin D: A Mini-Review Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Julia Fedotova, Filippo Drago, Lucia Gozzo, et al. (+3)
199 [GO] 2020―Dec―14 Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives Cheng-Wei Yang, Yue-Zhi Lee, Hsing-Yu Hsu, Jia-Tsrong Jan, Yi-Ling Lin, Sui-Yuan Chang, et al. (+15)
200 [GO] 2020―Dec―14 A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface Charlie Nichols, Joseph Ng, Annika Keshu, Franca Fraternali, Gian F. De Nicola
201 [GO] 2020―Dec―11 Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation Chengliang Yang, Shaf Keshavjee, Mingyao Liu
202 [GO] 2020―Dec―11 Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie, Pakiza Ruknudin, Pierre Hardy, Alain Rivard, Sylvain Chemtob
203 [GO] 2020―Dec―11 SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses Abdo A. Elfiky
204 [GO] 2020―Dec―10 Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review Giuliano Lo Bianco, Santi Di Pietro, Emilia Mazzuca, Aurelio Imburgia, Luca Tarantino, Giuseppe Accurso, et al. (+5)
205 [GO] 2020―Dec―09 Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism Mohamed Abu-Farha, Salman Al-Sabah, Maha M. Hammad, Prashantha Hebbar, Arshad Mohamed Channanath, Sumi Elsa John, et al. (+8)
206 [GO] 2020―Dec―07 Hydroxychloroquine in COVID-19 Patients: Pros and Cons Nour K. Younis, Rana O. Zareef, Sally N. Al Hassan, Fadi Bitar, Ali H. Eid, Mariam Arabi
207 [GO] 2020―Dec―03 Hydroxychloroquine as Prophylaxis for COVID-19: A Review Manuela Monti, Bernadette Vertogen, Carla Masini, Caterina Donati, Claudia Lilli, Chiara Zingaretti, et al. (+8)
208 [GO] 2020―Dec―03 Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi, Daniela Marasco
209 [GO] 2020―Nov―30 Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago
210 [GO] 2020―Nov―30 A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China Nan Zhang, Nannan Shi, Siyu Li, Guoxiu Liu, Yonglong Han, Li Liu, et al. (+25)
211 [GO] 2020―Nov―30 Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience Aurélien Mary, Lucie Hénaut, Pierre Yves Macq, Louise Badoux, Arnaud Cappe, Thierry Porée, et al. (+3)
212 [GO] 2020―Nov―26 Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities Jonathan D. Geiger, Nabab Khan, Madhuvika Murugan, Detlev Boison
213 [GO] 2020―Nov―26 Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration Qianqian Li, Chen Bai, Ruocong Yang, Weiying Xing, Xiaohan Pang, Siying Wu, et al. (+4)
214 [GO] 2020―Nov―26 Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches Federica Mannino, Alessandra Bitto, Natasha Irrera
215 [GO] 2020―Nov―25 An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2 Roodabeh Bahramsoltani, Roja Rahimi
216 [GO] 2020―Nov―20 Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019 Mudasir S. Andrabi, Shaida A. Andrabi
217 [GO] 2020―Nov―20 Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner
218 [GO] 2020―Nov―19 Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, et al. (+3)
219 [GO] 2020―Nov―18 Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, Narges Kiyani, Katrina Stage, Pantea Mohammadi, et al. (+3)
220 [GO] 2020―Nov―17 A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs Po-Lin Chen, Nan-Yao Lee, Cong-Tat Cia, Wen-Chien Ko, Po-Ren Hsueh
221 [GO] 2020―Nov―13 Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment Niteen A. Vaidya, Renu Vyas
222 [GO] 2020―Nov―09 Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? José Miguel Vela
223 [GO] 2020―Nov―09 Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review Qin Qiu, Yuge Huang, Xiaohua Liu, Fangfang Huang, Xiaoling Li, Liao Cui, et al. (+2)
224 [GO] 2020―Nov―06 Challenges for Drug Repurposing in the COVID-19 Pandemic Era Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir, Gianluca Trifirò
225 [GO] 2020―Nov―06 Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, et al. (+12)
226 [GO] 2020―Nov―06 Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019 Prakash Nagarkatti, Kathryn Miranda, Mitzi Nagarkatti
227 [GO] 2020―Oct―29 Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019 Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra
228 [GO] 2020―Oct―29 Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments Nabab Khan, Xuesong Chen, Jonathan D. Geiger
229 [GO] 2020―Oct―28 Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19 Hongwei Peng, Zhangren Chen, Yunyun Wang, Simei Ren, Tiantian Xu, Xin Lai, et al. (+9)
230 [GO] 2020―Oct―28 Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, Gioconda Saccoccio, Alessandro Rizzo, Elisabetta Poluzzi, et al. (+2)
231 [GO] 2020―Oct―22 Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study Bo Zhang, Yuanhang Yu, Shawna Herbet, Yue Zhang, Jianhua Lu, Shihua Liu, et al. (+6)
232 [GO] 2020―Oct―22 Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice) Decio Armanini, Cristina Fiore, Jens Bielenberg, Chiara Sabbadin, Luciana Bordin
233 [GO] 2020―Oct―16 Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease Devinder Toor, Aklank Jain, Shivani Kalhan, Harmesh Manocha, Vivek Kumar Sharma, Payal Jain, et al. (+2)
234 [GO] 2020―Oct―16 COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management Md. Farhad Hossain, Sharifa Hasana, Abdullah Al Mamun, Md. Sahab Uddin, Mir Imam Ibne Wahed, Sabarni Sarker, et al. (+11)
235 [GO] 2020―Oct―16 Current Prevention of COVID-19: Natural Products and Herbal Medicine Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang, Jia-xu Chen
236 [GO] 2020―Oct―15 Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients Fuxun Yang, Ruiming Yue, Xiaoxiu Luo, Rongan Liu, Xiaobo Huang
237 [GO] 2020―Oct―14 Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection Maryam S. Al-Motawa, Hafsa Abbas, Patrick Wijten, Alberto de la Fuente, Mingzhan Xue, Naila Rabbani, Paul J. Thornalley
238 [GO] 2020―Oct―09 Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, Tsong-Long Hwang
239 [GO] 2020―Oct―08 Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients Vincenzo Russo, Andreina Carbone, Filiberto Fausto Mottola, Rosa Mocerino, Raffaele Verde, Emilio Attena, et al. (+6)
240 [GO] 2020―Oct―08 “Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study Zhongzhu Ai, Shanshan Zhou, Weinan Li, Mengfan Wang, Linqun Wang, Gangming Hu, et al. (+7)
241 [GO] 2020―Oct―07 COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence Hana Abdelzaher, Basma M. Saleh, Hebatalla A. Ismail, Marwa Hafiz, Macy Abou Gabal, Miranda Mahmoud, et al. (+4)
242 [GO] 2020―Oct―07 Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Piero Sestili, Carmela Fimognari
243 [GO] 2020―Oct―07 Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study Shaobin He, Jiaxing Tian, Xiaodong Li, Yana Zhou, Mingzhong Xiao, Ying Zhang, et al. (+19)
244 [GO] 2020―Oct―06 Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines Rajnish Kumar, Janmejai Kumar Srivastava, Rachana Singh, Mohammed Haris Siddiqui, Rasha A. Mansouri, Jawaher A. Abdulhakim, et al. (+4)
245 [GO] 2020―Oct―02 Mapping Evidence of Pharmacy Services for COVID-19 in China Zhan-Miao Yi, Yang Hu, Guan-Ru Wang, Rong-Sheng Zhao
246 [GO] 2020―Sep―25 Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19) Surjeet Verma, Danielle Twilley, Tenille Esmear, Carel B. Oosthuizen, Anna-Mari Reid, Marizé Nel, Namrita Lall
247 [GO] 2020―Sep―25 The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic Xiao-rui Zhang, Ting-na Li, Yuan-yuan Ren, Yi-jia Zeng, Hong-yang Lv, Jin Wang, Qin-wan Huang
248 [GO] 2020―Sep―25 The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago
249 [GO] 2020―Sep―24 COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Dâmaris Silveira, Jose Maria Prieto-Garcia, Fabio Boylan, Omar Estrada, Yris Maria Fonseca-Bazzo, Claudia Masrouah Jamal, et al. (+4)
250 [GO] 2020―Sep―18 Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study Jie Fang, Hui Li, Wei Du, Ping Yu, Ying-Yun Guan, Shi-Yu Ma, et al. (+4)
251 [GO] 2020―Sep―17 Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena Arghadip Samaddar, Malika Grover, Vijaya Lakshmi Nag
252 [GO] 2020―Sep―16 In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis Chenliang Ge, Yan He
253 [GO] 2020―Sep―16 Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital Jesús Miguel García-Menaya, Concepción Cordobés-Durán, Juan Francisco Rangel-Mayoral, Elena García-Martín, José A. G. Agúndez
254 [GO] 2020―Sep―16 Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence Filippo Drago, Lucia Gozzo, Li Li, Andrea Stella, Benilde Cosmi
255 [GO] 2020―Sep―15 Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19 Tengwen Liu, Yuhong Guo, Jingxia Zhao, Shasha He, Yunjing Bai, Ning Wang, et al. (+3)
256 [GO] 2020―Sep―15 The Potential of Antiviral Peptides as COVID-19 Therapeutics Arun Suria Karnan Mahendran, Yin Sze Lim, Chee-Mun Fang, Hwei-San Loh, Cheng Foh Le
257 [GO] 2020―Sep―15 Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives Chandan Sarkar, Milon Mondal, Muhammad Torequl Islam, Miquel Martorell, Anca Oana Docea, Alfred Maroyi, et al. (+2)
258 [GO] 2020―Sep―11 Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, R. Andrew Seaton, Adesola F. Yinka-Ogunleye, et al. (+66)
259 [GO] 2020―Sep―11 Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine Chuan-hong Luo, Le-le Ma, Hui-min Liu, Wei Liao, Run-chun Xu, Zhi-min Ci, et al. (+3)
260 [GO] 2020―Sep―10 Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis Zhihuan Zhou, Ning Gao, Yumeng Wang, Pengcheng Chang, Yi Tong, Shufei Fu
261 [GO] 2020―Sep―09 Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis Krishna P. Maremanda, Isaac K. Sundar, Dongmei Li, Irfan Rahman
262 [GO] 2020―Sep―09 Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis Wenwen Cheng, Yufeng Li, Liyan Cui, Ying Chen, Sharui Shan, Duan Xiao, et al. (+3)
263 [GO] 2020―Sep―04 Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence Jean Barré, Jean-Marc Sabatier, Cédric Annweiler
264 [GO] 2020―Sep―04 Potential Application of Drosophila melanogaster as a Model Organism in COVID-19-Related Research Firzan Nainu, Dini Rahmatika, Talha Bin Emran, Harapan Harapan
265 [GO] 2020―Sep―03 Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit? Cuicui Lu, Ning Hou
266 [GO] 2020―Sep―02 Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis Lin-Lu Ma, Xuan Yin, Bing-Hui Li, Jia-Yu Yang, Ying-Hui Jin, Di Huang, et al. (+5)
267 [GO] 2020―Aug―28 Immunosuppressive Drugs and COVID-19: A Review Tessa S. Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum
268 [GO] 2020―Aug―28 Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2 Priya Gatti, Hema Saranya Ilamathi, Kiran Todkar, Marc Germain
269 [GO] 2020―Aug―27 Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, Daniela Rodrígues-Amorím, José M. Olivares
270 [GO] 2020―Aug―27 Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019 Jiaxing Zhang, Yiling Lu, Joey Sum-wing Kwong, Xiaosi Li, Wenyi Zheng, Rui He
271 [GO] 2020―Aug―27 Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019 Chunsheng Zhu, Bao Sun, Xiaochuan Zhang, Bing Zhang
272 [GO] 2020―Aug―26 SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus Simona Iacob, Diana Gabriela Iacob
273 [GO] 2020―Aug―21 Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic Xiaoye Li, Chengchun Zuo, Wenjing Lu, Ye Zou, Qing Xu, Xiaoyu Li, Qianzhou Lv
274 [GO] 2020―Aug―21 The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review Lucia Gozzo, Pierluigi Viale, Laura Longo, Daniela Cristina Vitale, Filippo Drago
275 [GO] 2020―Aug―20 Harnessing Memory NK Cell to Protect Against COVID-19 Saeede Soleimanian, Ramin Yaghobi
276 [GO] 2020―Aug―19 Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19 Rudra P. Saha, Ashish Ranjan Sharma, Manoj K. Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, et al. (+3)
277 [GO] 2020―Aug―14 COVID-19 Usurps Host Regulatory Networks Colleen S. Curran, Donna R. Rivera, Jeffrey B. Kopp
278 [GO] 2020―Aug―13 A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes Colin D. Funk, Ali Ardakani
279 [GO] 2020―Aug―13 COVID-19 Therapeutic Options Under Investigation Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, et al. (+3)
280 [GO] 2020―Aug―12 Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China Yiming Ma, Huihui Zeng, Zijie Zhan, Huanhuan Lu, Zihang Zeng, Chenjie He, et al. (+13)
281 [GO] 2020―Aug―11 Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, Francesco Donati, Maddalena Giannella, Sara Tedeschi, et al. (+8)
282 [GO] 2020―Aug―07 Medicinal Plants as Sources of Active Molecules Against COVID-19 Bachir Benarba, Atanasio Pandiella
283 [GO] 2020―Aug―07 DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F. Sánchez-Ferrer, Jürgen Eckel, Tania Romacho
284 [GO] 2020―Aug―05 DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients? Andrija Smelcerovic, Gordana Kocic, Mihajlo Gajic, Katarina Tomovic, Vukica Djordjevic, Dobrila Stankovic-Djordjevic, Marko Anderluh
285 [GO] 2020―Jul―31 Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use Yan Chen, TaiPeng Shen, LiJun Zhong, ZhiXi Liu, XinWei Dong, TingWenLi Huang, et al. (+2)
286 [GO] 2020―Jul―29 Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention John P. Hussman
287 [GO] 2020―Jul―29 Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients Giorgio Zauli, Veronica Tisato, Paola Secchiero
288 [GO] 2020―Jul―17 Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19 Zeming Liu, Jinpeng Li, Danyang Chen, Rongfen Gao, Wen Zeng, Sichao Chen, et al. (+7)
289 [GO] 2020―Jul―17 Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, et al. (+6)
290 [GO] 2020―Jul―16 The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection Jesus Acosta-Elias, Ricardo Espinosa-Tanguma
291 [GO] 2020―Jul―15 Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option? Alba Calderone, Francesco Menichetti, Ferruccio Santini, Luciano Colangelo, Ersilia Lucenteforte, Vincenzo Calderone
292 [GO] 2020―Jul―14 No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study Yin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, Yan-Ming Zeng, Xiao-Qing He, Yao Li, et al. (+9)
293 [GO] 2020―Jul―10 Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy Tomohiko Aoe
294 [GO] 2020―Jul―09 BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? Siya Kamat, Madhuree Kumari
295 [GO] 2020―Jul―02 Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection Zhonglei Wang, Liyan Yang
296 [GO] 2020―Jun―24 Pharmacotherapics Advice in Guidelines for COVID-19 Zhang-Ren Chen, Ying Zhou, Jin Liu, Hong-Wei Peng, Jian Zhou, Hai-Li Zhong, et al. (+4)
297 [GO] 2020―Jun―24 Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
298 [GO] 2020―Jun―19 Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 Maria Laura Belladonna, Ciriana Orabona
299 [GO] 2020―Jun―19 A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Colin D. Funk, Craig Laferrière, Ali Ardakani
300 [GO] 2020―Jun―12 New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection Shijia Yan, Haixia Sun, Xianzhang Bu, Guohui Wan
301 [GO] 2020―Jun―05 Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19 Piero Sestili, Vilberto Stocchi
302 [GO] 2020―Jun―05 Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 Teluguakula Narasaraju, Benjamin M. Tang, Martin Herrmann, Sylviane Muller, Vincent T. K. Chow, Marko Radic
303 [GO] 2020―Jun―05 Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study Valentina Giudice, Pasquale Pagliano, Alessandro Vatrella, Alfonso Masullo, Sergio Poto, Benedetto Maria Polverino, et al. (+10)
304 [GO] 2020―May―29 An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Giuseppe Terrazzano, Valentina Rubino, Anna Teresa Palatucci, Angela Giovazzino, Flavia Carriero, Giuseppina Ruggiero
305 [GO] 2020―May―26 Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19? Mekonnen Sisay
306 [GO] 2020―May―01 The Zebrafish Disease and Drug Screening Model: A Strong Ally Against Covid-19 Jorge Galindo-Villegas


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.120 sec